Late CMV Disease in D+/R- Solid Organ Recipients Receiving Alemtuzumab Induction Despite One Year of Prophylaxis
Principal Investigator
Study Number
STUDY02001633
Available at the following location(s)
- Lebanon
Do you need help with some of the labels on this page?
Read our glossary of terms